The utility of wearable devices in assessing ambulatory impairments of people with multiple sclerosis in free-living conditions
Authors:
Shaoxiong Sun,
Amos A Folarin,
Yuezhou Zhang,
Nicholas Cummins,
Shuo Liu,
Callum Stewart,
Yatharth Ranjan,
Zulqarnain Rashid,
Pauline Conde,
Petroula Laiou,
Heet Sankesara,
Gloria Dalla Costa,
Letizia Leocani,
Per Soelberg Sørensen,
Melinda Magyari,
Ana Isabel Guerrero,
Ana Zabalza,
Srinivasan Vairavan,
Raquel Bailon,
Sara Simblett,
Inez Myin-Germeys,
Aki Rintala,
Til Wykes,
Vaibhav A Narayan,
Matthew Hotopf
, et al. (3 additional authors not shown)
Abstract:
Multiple sclerosis (MS) is a progressive inflammatory and neurodegenerative disease of the central nervous system affecting over 2.5 million people globally. In-clinic six-minute walk test (6MWT) is a widely used objective measure to evaluate the progression of MS. Yet, it has limitations such as the need for a clinical visit and a proper walkway. The widespread use of wearable devices capable of…
▽ More
Multiple sclerosis (MS) is a progressive inflammatory and neurodegenerative disease of the central nervous system affecting over 2.5 million people globally. In-clinic six-minute walk test (6MWT) is a widely used objective measure to evaluate the progression of MS. Yet, it has limitations such as the need for a clinical visit and a proper walkway. The widespread use of wearable devices capable of depicting patients activity profiles has the potential to assess the level of MS-induced disability in free-living conditions. In this work, we extracted 96 activity features in different temporal granularities (from minute-level to day-level) and explored their utility in estimating 6MWT scores in a European (Italy, Spain, and Denmark) MS cohort of 337 participants over an average of 10-month duration. We combined these features with participant demographics using three regression models including elastic net, gradient boosted trees and random forest. In addition, we quantified the individual feature contribution using feature importance in these regression models, linear mixed-effects models, generalized estimating equations, and correlation-based feature selection (CFS). The results showed promising estimation performance with R2 of 0.30, which was derived using random forest after CFS. This model was able to distinguish the participants with low disability from those with high disability. Furthermore, we observed that the minute-level (no longer than 8 minutes) step count, particularly those capturing the upper end of the step count distribution, had a stronger association with 6MWT. The use of a walking aid was indicative of ambulatory function measured through 6MWT. This study provides a basis for future investigation into the clinical relevance and utility of wearables in assessing MS progression in free-living conditions.
△ Less
Submitted 22 December, 2021;
originally announced December 2021.
Fitbeat: COVID-19 Estimation based on Wristband Heart Rate
Authors:
Shuo Liu,
**g Han,
Estela Laporta Puyal,
Spyridon Kontaxis,
Shaoxiong Sun,
Patrick Locatelli,
Judith Dineley,
Florian B. Pokorny,
Gloria Dalla Costa,
Letizia Leocan,
Ana Isabel Guerrero,
Carlos Nos,
Ana Zabalza,
Per Soelberg Sørensen,
Mathias Buron,
Melinda Magyari,
Yatharth Ranjan,
Zulqarnain Rashid,
Pauline Conde,
Callum Stewart,
Amos A Folarin,
Richard JB Dobson,
Raquel Bailón,
Srinivasan Vairavan,
Nicholas Cummins
, et al. (4 additional authors not shown)
Abstract:
This study investigates the potential of deep learning methods to identify individuals with suspected COVID-19 infection using remotely collected heart-rate data. The study utilises data from the ongoing EU IMI RADAR-CNS research project that is investigating the feasibility of wearable devices and smart phones to monitor individuals with multiple sclerosis (MS), depression or epilepsy. Aspart of…
▽ More
This study investigates the potential of deep learning methods to identify individuals with suspected COVID-19 infection using remotely collected heart-rate data. The study utilises data from the ongoing EU IMI RADAR-CNS research project that is investigating the feasibility of wearable devices and smart phones to monitor individuals with multiple sclerosis (MS), depression or epilepsy. Aspart of the project protocol, heart-rate data was collected from participants using a Fitbit wristband. The presence of COVID-19 in the cohort in this work was either confirmed through a positive swab test, or inferred through the self-reporting of a combination of symptoms including fever, respiratory symptoms, loss of smell or taste, tiredness and gastrointestinal symptoms. Experimental results indicate that our proposed contrastive convolutional auto-encoder (contrastive CAE), i. e., a combined architecture of an auto-encoder and contrastive loss, outperforms a conventional convolutional neural network (CNN), as well as a convolutional auto-encoder (CAE) without using contrastive loss. Our final contrastive CAE achieves 95.3% unweighted average recall, 86.4% precision, anF1 measure of 88.2%, a sensitivity of 100% and a specificity of 90.6% on a testset of 19 participants with MS who reported symptoms of COVID-19. Each of these participants was paired with a participant with MS with no COVID-19 symptoms.
△ Less
Submitted 19 April, 2021;
originally announced April 2021.
